Rocket Pharmaceuticals announced that Janet Chung, Ph.D., will participate as a speaker on the BioProcess International US 2026 Conference & Exhibition in Boston from September 22-25, 2026.
Public source
Publisher name
Public post
I am thrilled to announce my participation as a speaker on the flagship BioProcess International US 2026 Conference & Exhibition, held September 22-25, 2026 in Boston. B…
Company
Rocket Pharmaceuticals
Seeking gene therapy cures
- Industry
- Biotechnology
- Location
- Cranbury, US
- Company size
- 201–500 employees
About Rocket Pharmaceuticals
Rocket Pharma (NASDAQ: RCKT) is a fully-integrated, clinical-stage company seeking gene therapy cures. Rocket places enormous value on people and takes team member progress and well-being just as seriously as the progress and well-being of its pipeline. We are looking for hands-on team players that enjoy collaborating with colleagues who share a passion for our mission and making a difference for patients. Become an integral part of an agile, highly productive team and help grow an entrepreneurial, scientifically driven organization that is increasingly recognized as a leading biotechnology innovator. In addition to a competitive compensation package featuring a generous 401K match and stock options, positions include excellent health benefits. For more information, please visit www.rocketpharma.com. Twitter: https://bit.ly/2O28aHx YouTube: https://bit.ly/3iNSXIu
See moreLatest activity
Latest activity from Rocket Pharmaceuticals
4 signals
Presence & Recognition
Rocket Pharmaceuticals represented at the American Society of Gene + Cell Therapy's 2026 Policy Summit on September 14 in Washington, D.C., for a panel discussion on hot topics in regulatory policy.
Presence & Recognition
Rocket Pharmaceuticals team Rocket is joining the FIA Foundation for Inherited Arrhythmias in recognizing Inherited Arrhythmias Awareness Month
Presence & Recognition
Rocket Pharmaceuticals is participating in Pediatric Cardiomyopathy Awareness Month by standing with the Children's Cardiomyopathy Foundation.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Scholar Rock
Scholar Rock is participating in two upcoming investor conferences in New York, NY, scheduled for Wednesday, September 9 at the Cantor 2026 Global Healthcare Conference and Thursday, September 10 at the Citi 2026 BioPharma Back to School Conference.
Presence & Recognition
BridgeBio
BridgeBio announced a late-breaking oral presentation on the impact of oral infigratinib on medical complications in achondroplasia from PROPEL 3 at the Annual European Society for Paediatric Endocrinology meeting 2026.
Presence & Recognition
Apertura Gene Therapy
Apertura Gene Therapy employee Jorge Santiago-Ortiz, Ph.D., will speak on enabling IV, brain-wide AAV gene delivery through an FDA-informed, GMP-ready platform at the 2026 Advanced Therapies Europe Conference in Barcelona on Tuesday, September 8.
Presence & Recognition
ProBio
ProBio is attending the BioProcess International 2026 conference in Boston from September 22 to 25, featuring Booth 931 to discuss development and manufacturing strategies for advanced biologics and cell and gene therapies.
Presence & Recognition
SanegeneBio